FEB 16, 2026夜盘交易 20:00 - 04:00
ET 03:00
IMP4.0
SNT+1.0
CONF80%
Operational

AMD and Tata Consultancy Services Expand AI Collaboration

AMD and Tata Consultancy Services (TCS) announced an expanded partnership to advance AI and high-performance computing solutions. The collaboration will focus on developing optimized AI workloads and cloud-native applications, leveraging AMD's EPYC processors and TCS's industry expertise.
The agreement builds on their existing relationship, aiming to deliver scalable, secure AI infrastructure for enterprises. While financial details were not disclosed, the partnership underscores growing demand for AI-capable computing platforms. AMD (AMD) and TCS (TCS) expect initial solutions to be available in the second half of 2026.

AMD and Tata Consultancy Services (TCS) announced an expanded partnership to advance AI and high-performance computing solutions. The collaboration will focus on developing optimized AI workloads and cloud-native applications, leveraging AMD's EPYC processors and TCS's industry expertise.

The agreement builds on their existing relationship, aiming to deliver scalable, secure AI infrastructure for enterprises. While financial details were not disclosed, the partnership underscores growing demand for AI-capable computing platforms. AMD (AMD) and TCS (TCS) expect initial solutions to be available in the second half of 2026.

ET 02:58

Three Low-Cost Stocks Under $10 to Avoid: DOMO, DNUT, IEP

StockStory identifies three sub-$10 stocks with significant risk factors: Domo (DOMO), Krispy Kreme (DNUT), and Icahn Enterprises (IEP). These companies exhibit concerning metrics and business dynamics that warrant caution or outright avoidance.
DOMO trades at $4.10 (0.6x forward P/S), DNUT at $2.97 (14.3x forward EV/EBITDA), and IEP at $8.13 (0.5x forward P/S). Each faces operational or valuation headwinds that could limit upside potential. Investors seeking quality exposure should consult StockStory's curated list of high-quality stocks, which delivered a 244% five-year return through June 30, 2025.

StockStory identifies three sub-$10 stocks with significant risk factors: Domo (DOMO), Krispy Kreme (DNUT), and Icahn Enterprises (IEP). These companies exhibit concerning metrics and business dynamics that warrant caution or outright avoidance.

DOMO trades at $4.10 (0.6x forward P/S), DNUT at $2.97 (14.3x forward EV/EBITDA), and IEP at $8.13 (0.5x forward P/S). Each faces operational or valuation headwinds that could limit upside potential. Investors seeking quality exposure should consult StockStory's curated list of high-quality stocks, which delivered a 244% five-year return through June 30, 2025.

ET 02:58
IMP4.0
SNT-1.0
CONF100%
Earnings

Domo (DOMO) Under Pressure: Billings Flat, CAC Payback Negative, Analysts See Limited Upside

Domo Inc. (DOMO) faces headwinds as billings stagnated at $73.2 million in the latest quarter, signaling struggles in customer acquisition and retention. Analysts forecast just 1.3% revenue growth over the next 12 months, below the company's five-year 9.8% annualized pace. The customer acquisition cost (CAC) payback turned negative, indicating sales and marketing outpacing revenue. DOMO now trades at $4.10 (0.6× forward P/S), raising concerns about shaky fundamentals despite the low valuation.

Domo Inc. (DOMO) faces headwinds as billings stagnated at $73.2 million in the latest quarter, signaling struggles in customer acquisition and retention. Analysts forecast just 1.3% revenue growth over the next 12 months, below the company's five-year 9.8% annualized pace. The customer acquisition cost (CAC) payback turned negative, indicating sales and marketing outpacing revenue. DOMO now trades at $4.10 (0.6× forward P/S), raising concerns about shaky fundamentals despite the low valuation.

ET 02:58
IMP2.0
SNT+0.3
CONF80%
Narrative

GE Vernova (GEV) Lacks Sustained Growth Despite 28.4% Gain; Analysts Prefer Alternative

GE Vernova (GEV) shares reached $802.45, up 28.4% in six months, outpacing the S&P 500 by 22.5%. Despite strong recent performance, analysts advise caution due to lackluster long-term growth metrics.
Over four years, GEV's sales grew at a 3.6% CAGR, below industry standards. Unit economics are weak, with a 16.2% gross margin and an average -1.4% operating margin over five years. At 58.2x forward P/E, valuation appears stretched. Analysts recommend considering alternative investments with stronger fundamentals.

GE Vernova (GEV) shares reached $802.45, up 28.4% in six months, outpacing the S&P 500 by 22.5%. Despite strong recent performance, analysts advise caution due to lackluster long-term growth metrics.

Over four years, GEV's sales grew at a 3.6% CAGR, below industry standards. Unit economics are weak, with a 16.2% gross margin and an average -1.4% operating margin over five years. At 58.2x forward P/E, valuation appears stretched. Analysts recommend considering alternative investments with stronger fundamentals.

ET 02:48
IMP6.0
SNT-1.0
CONF70%
Narrative

Analysts Recommend Selling Home Bancshares (HOMB) in Favor of Semiconductor Stocks

Analysts at StockStory advise selling Home Bancshares (HOMB) and reallocating to semiconductor stocks. HOMB trades at $29.35, up 3.1% in six months, underperforming peers.
Key concerns: 5-year revenue CAGR 9.2%, net interest income 8.9%, and EPS CAGR 6.2%—all lagging industry averages. Valuation at 1.3× forward P/B is fair but not compelling given weaker profitability.
Instead, consider semiconductor "picks and shovels" plays. The Top 9 Market-Beating Stocks list, updated to June 30, 2025, delivered 244% returns vs. the market, including Nvidia (+1,326%) and Exlservice (+354%).

Analysts at StockStory advise selling Home Bancshares (HOMB) and reallocating to semiconductor stocks. HOMB trades at $29.35, up 3.1% in six months, underperforming peers.

Key concerns: 5-year revenue CAGR 9.2%, net interest income 8.9%, and EPS CAGR 6.2%—all lagging industry averages. Valuation at 1.3× forward P/B is fair but not compelling given weaker profitability.

Instead, consider semiconductor "picks and shovels" plays. The Top 9 Market-Beating Stocks list, updated to June 30, 2025, delivered 244% returns vs. the market, including Nvidia (+1,326%) and Exlservice (+354%).

ET 02:48
IMP4.0
SNT+0.8
CONF90%
Earnings

DXP (DXPE) Stock Analysis: 439% Gain Since 2021, 23x Forward P/E

DXP Enterprises (DXPE) shares trade at $148.68, up 439% since February 2021, outpacing the S&P 500's 73.7% return. The industrial distributor posted a 22.4% gain over the past six months.
DXP, founded during Texas' Big Oil era, supplies pumps, valves, and industrial components. Revenue grew at a 13% annualized rate over five years, with operating margins expanding 5.1 percentage points to 8.7%. Earnings per share surged at a 50.1% CAGR, exceeding revenue growth. Valued at 23x forward P/E, the stock's long-term quality metrics remain strong.

DXP Enterprises (DXPE) shares trade at $148.68, up 439% since February 2021, outpacing the S&P 500's 73.7% return. The industrial distributor posted a 22.4% gain over the past six months.

DXP, founded during Texas' Big Oil era, supplies pumps, valves, and industrial components. Revenue grew at a 13% annualized rate over five years, with operating margins expanding 5.1 percentage points to 8.7%. Earnings per share surged at a 50.1% CAGR, exceeding revenue growth. Valued at 23x forward P/E, the stock's long-term quality metrics remain strong.

ET 02:30
IMP6.0
SNT+1.0
CONF60%
Regulatory

Sanofi: Beyfortus RSV Study Shows Benefits Extend Beyond First Season

Sanofi SA (SNY) announced new data from a phase 3 trial of Beyfortus (nirsevimab), showing protection against respiratory syncytial virus (RSV) in infants extends into a second RSV season. The results, presented at a medical conference, support Beyfortus as a single-dose preventive for RSV in infants and young children.
In the trial, Beyfortus demonstrated sustained neutralizing antibody levels and efficacy through a second RSV season in infants born during the study. Sanofi said the findings reinforce Beyfortus's role in reducing RSV-related lower respiratory tract infections. The company is seeking expanded approval for Beyfortus, which is already approved for RSV prevention in infants and young children.

Sanofi SA (SNY) announced new data from a phase 3 trial of Beyfortus (nirsevimab), showing protection against respiratory syncytial virus (RSV) in infants extends into a second RSV season. The results, presented at a medical conference, support Beyfortus as a single-dose preventive for RSV in infants and young children.

In the trial, Beyfortus demonstrated sustained neutralizing antibody levels and efficacy through a second RSV season in infants born during the study. Sanofi said the findings reinforce Beyfortus's role in reducing RSV-related lower respiratory tract infections. The company is seeking expanded approval for Beyfortus, which is already approved for RSV prevention in infants and young children.

ET 02:26
IMP4.0
SNT0.0
CONF70%
Earnings

Pitney Bowes (PBI) to Report Q4 Earnings After Tuesday Close

Pitney Bowes (NYSE: PBI) will release fourth-quarter earnings after the market closes on February 16, 2026. The shipping and mailing solutions provider is expected to report revenue of $482.5 million, down 6.5% year-over-year, with adjusted EPS of $0.38.
Analysts have largely maintained their estimates over the past 30 days, signaling stability. However, PBI has missed revenue expectations six times in the past two years. Peer results suggest mixed outcomes: Tetra Tech beat estimates by 6.4% and rose 3%, while UniFirst topped forecasts by 1% with no price change. PBI's shares are up 2.6% in the last month, trading at $10.28 with an average price target of $13.

Pitney Bowes (NYSE: PBI) will release fourth-quarter earnings after the market closes on February 16, 2026. The shipping and mailing solutions provider is expected to report revenue of $482.5 million, down 6.5% year-over-year, with adjusted EPS of $0.38.

Analysts have largely maintained their estimates over the past 30 days, signaling stability. However, PBI has missed revenue expectations six times in the past two years. Peer results suggest mixed outcomes: Tetra Tech beat estimates by 6.4% and rose 3%, while UniFirst topped forecasts by 1% with no price change. PBI's shares are up 2.6% in the last month, trading at $10.28 with an average price target of $13.

ET 02:08

JB Hi-Fi H1 Profit Rises 11.6% to A$384.2M

Australian retailer JB Hi-Fi (JBH.AX) reported a 11.6% rise in first-half profit to A$384.2 million for the period ending December 27, 2025. Revenue climbed 8.4% to A$3.78 billion, driven by strong demand for home entertainment and appliances. The company raised its final dividend by 15% to 40 cents per share. JB Hi-Fi cited disciplined pricing and cost controls for the outperformance amid inflationary pressures.

Australian retailer JB Hi-Fi (JBH.AX) reported a 11.6% rise in first-half profit to A$384.2 million for the period ending December 27, 2025. Revenue climbed 8.4% to A$3.78 billion, driven by strong demand for home entertainment and appliances. The company raised its final dividend by 15% to 40 cents per share. JB Hi-Fi cited disciplined pricing and cost controls for the outperformance amid inflationary pressures.

ET 02:08
IMP4.0
SNT+1.0
CONF100%
Operational

Cognizant (CTSH) Expands Google Cloud Partnership to Scale Agentic AI Deployment

Cognizant Technology Solutions Corp. (CTSH) announced an expanded partnership with Google Cloud to accelerate the deployment of agentic AI solutions for clients. The collaboration will focus on developing and scaling AI-powered services across industries, leveraging Google Cloud's infrastructure and Cognizant's industry expertise.
The agreement builds on a long-standing relationship, aiming to deliver more advanced AI capabilities to enterprises. No financial terms were disclosed. This move underscores Cognizant's strategy to deepen its AI offerings amid growing demand for generative AI services.

Cognizant Technology Solutions Corp. (CTSH) announced an expanded partnership with Google Cloud to accelerate the deployment of agentic AI solutions for clients. The collaboration will focus on developing and scaling AI-powered services across industries, leveraging Google Cloud's infrastructure and Cognizant's industry expertise.

The agreement builds on a long-standing relationship, aiming to deliver more advanced AI capabilities to enterprises. No financial terms were disclosed. This move underscores Cognizant's strategy to deepen its AI offerings amid growing demand for generative AI services.

ET 02:08

Aurizon H1 Results Climb; Names Ian Wells CFO, Effective April 7

Aurizon Holdings (ASX: AZJ) reported a 12.5% rise in first-half net profit to A$414 million, driven by higher freight volumes and improved operational efficiency. The Australian rail and logistics company also announced Ian Wells as CFO, effective April 7, 2026, succeeding outgoing CFO Michael Thompson.
Revenue climbed 8.7% to A$2.45 billion, with underlying EBITDA up 10.2% to A$896 million. The board declared an interim dividend of 10 cents per share, unchanged from last year. Wells brings 15 years of experience in transport and infrastructure finance, most recently as finance director at Queensland Rail.

Aurizon Holdings (ASX: AZJ) reported a 12.5% rise in first-half net profit to A$414 million, driven by higher freight volumes and improved operational efficiency. The Australian rail and logistics company also announced Ian Wells as CFO, effective April 7, 2026, succeeding outgoing CFO Michael Thompson.

Revenue climbed 8.7% to A$2.45 billion, with underlying EBITDA up 10.2% to A$896 million. The board declared an interim dividend of 10 cents per share, unchanged from last year. Wells brings 15 years of experience in transport and infrastructure finance, most recently as finance director at Queensland Rail.

ET 02:08

Genentech Reports Positive Phase III Results for Gazyva in Primary Membranous Nephropathy

Genentech, a member of the Roche Group, announced positive topline results from the Phase III GEMMA trial evaluating Gazyva (obinutuzumab) in combination with glucocorticoids for the treatment of primary membranous nephropathy (PMN). The trial met its primary endpoint of complete or partial renal response at week 24 compared to placebo plus glucocorticoids. Gazyva is already approved for certain types of blood cancers; this data supports its potential expansion into kidney disease.
The GEMMA study enrolled 330 patients across multiple countries. Gazyva demonstrated a statistically significant improvement in renal response rates without increasing serious adverse events. Genentech plans to submit the data to global health authorities in the coming months for potential approval in PMN. Shares of Roche Holdings (ROG.VX) were up 1.2% in early trading.

Genentech, a member of the Roche Group, announced positive topline results from the Phase III GEMMA trial evaluating Gazyva (obinutuzumab) in combination with glucocorticoids for the treatment of primary membranous nephropathy (PMN). The trial met its primary endpoint of complete or partial renal response at week 24 compared to placebo plus glucocorticoids. Gazyva is already approved for certain types of blood cancers; this data supports its potential expansion into kidney disease.

The GEMMA study enrolled 330 patients across multiple countries. Gazyva demonstrated a statistically significant improvement in renal response rates without increasing serious adverse events. Genentech plans to submit the data to global health authorities in the coming months for potential approval in PMN. Shares of Roche Holdings (ROG.VX) were up 1.2% in early trading.

ET 01:45

Saudi Arabia Names Debt Vet Fahad Al-Saif as Investment Minister to Triple FDI

Saudi Arabia has appointed Fahad Al-Saif, a veteran banker who spearheaded the kingdom's debt program, as investment minister to triple annual foreign direct investment to $100 billion by 2030. Al-Saif replaces Khalid Al-Falih in a cabinet reshuffle.
Al-Saif, who led Saudi Arabia's record $21.5 billion bond sale in 2017, brings deep experience in international finance and fundraising. He previously worked at the Public Investment Fund and a Saudi bank backed by HSBC. His mandate includes attracting capital to support Crown Prince Mohammed bin Salman's diversification plan, with a focus on sectors like AI, tourism, and advanced manufacturing.

Saudi Arabia has appointed Fahad Al-Saif, a veteran banker who spearheaded the kingdom's debt program, as investment minister to triple annual foreign direct investment to $100 billion by 2030. Al-Saif replaces Khalid Al-Falih in a cabinet reshuffle.

Al-Saif, who led Saudi Arabia's record $21.5 billion bond sale in 2017, brings deep experience in international finance and fundraising. He previously worked at the Public Investment Fund and a Saudi bank backed by HSBC. His mandate includes attracting capital to support Crown Prince Mohammed bin Salman's diversification plan, with a focus on sectors like AI, tourism, and advanced manufacturing.

ET 01:45

Big Tech's $700B+ AI Spending Surge Raises Data Sovereignty Concerns in Europe

Global tech giants are projected to spend over $700 billion in 2026 on AI infrastructure, dwarfing European sovereign cloud investments and intensifying debates over data sovereignty.
Amazon leads with $200 billion in CapEx, followed by Alphabet ($185B), Microsoft ($145B), and Meta ($135B). Total AI-related CapEx is forecast to exceed $5 trillion by 2030. Nvidia, the primary beneficiary, will report earnings on February 25.
Europe's spending is forecast at €10.6 billion, a fraction of U.S. outlays. Mistral AI plans €1 billion in 2026 CapEx and a €1.2 billion data center in Sweden. U.S. firms are rolling out localized cloud zones to address European regulators, but critics say these remain dependent on U.S. parent companies.

Global tech giants are projected to spend over $700 billion in 2026 on AI infrastructure, dwarfing European sovereign cloud investments and intensifying debates over data sovereignty.

Amazon leads with $200 billion in CapEx, followed by Alphabet ($185B), Microsoft ($145B), and Meta ($135B). Total AI-related CapEx is forecast to exceed $5 trillion by 2030. Nvidia, the primary beneficiary, will report earnings on February 25.

Europe's spending is forecast at €10.6 billion, a fraction of U.S. outlays. Mistral AI plans €1 billion in 2026 CapEx and a €1.2 billion data center in Sweden. U.S. firms are rolling out localized cloud zones to address European regulators, but critics say these remain dependent on U.S. parent companies.

ET 01:36

Indian Shares Little Changed Amid Cautious Trading

Indian equities edged marginally higher on February 16, 2026, as investors adopted a cautious stance ahead of key inflation data. The Nifty 50 index closed up 0.12% at 19,423.70, while the S&P BSE Sensex gained 0.15% to 65,218.90.
Trading volumes were subdued, with gains limited to select sectors including pharmaceuticals and consumer staples. Market participants are awaiting the release of February's consumer price index (CPI) data later this week, which is expected to influence the Reserve Bank of India's monetary policy outlook.

Indian equities edged marginally higher on February 16, 2026, as investors adopted a cautious stance ahead of key inflation data. The Nifty 50 index closed up 0.12% at 19,423.70, while the S&P BSE Sensex gained 0.15% to 65,218.90.

Trading volumes were subdued, with gains limited to select sectors including pharmaceuticals and consumer staples. Market participants are awaiting the release of February's consumer price index (CPI) data later this week, which is expected to influence the Reserve Bank of India's monetary policy outlook.

ET 01:36

Contact Energy Profit Rises, Plans NZ$525M Raise; Offers King Country Buyout

New Zealand utility Contact Energy (CTE) reported a 12% rise in first-half profit to NZ$193 million, boosted by higher electricity prices and strong demand. The company plans a NZ$525 million equity raising to fund growth and debt reduction. Separately, Contact has offered to buyout King Country Energy, a smaller competitor, to expand its distribution network. The offer values King Country at NZ$150 million.

New Zealand utility Contact Energy (CTE) reported a 12% rise in first-half profit to NZ$193 million, boosted by higher electricity prices and strong demand. The company plans a NZ$525 million equity raising to fund growth and debt reduction. Separately, Contact has offered to buyout King Country Energy, a smaller competitor, to expand its distribution network. The offer values King Country at NZ$150 million.

ET 01:36
IMP6.0
SNT+1.0
CONF100%
Earnings

BlueScope Steel H1 Profit Rises, Announces Dividend and Buyback; H2 EBIT Outlook; Stock Falls

BlueScope Steel (BSL) reported a 12% increase in first-half profit to AUD 1.1 billion, driven by higher steel prices and strong demand. The company declared a final dividend of AUD 0.40 per share and authorized a AUD 500 million share buyback. BlueScope provided a cautious outlook for underlying EBIT in the second half due to expected price declines and higher input costs. Shares fell 3.5% post-announcement.

BlueScope Steel (BSL) reported a 12% increase in first-half profit to AUD 1.1 billion, driven by higher steel prices and strong demand. The company declared a final dividend of AUD 0.40 per share and authorized a AUD 500 million share buyback. BlueScope provided a cautious outlook for underlying EBIT in the second half due to expected price declines and higher input costs. Shares fell 3.5% post-announcement.

ET 01:36

SIA Passenger Traffic Drops 16.5% in January

Singapore Airlines reported a 16.5% year-on-year decline in passenger traffic for January 2026, with total revenue passenger kilometers (RPK) falling to 3.2 million. Capacity, measured in available seat kilometers (ASK), decreased 12.8% to 3.8 million. Load factor slipped 5.2 percentage points to 84.2%. The carrier attributed the drop to reduced demand on long-haul routes and capacity adjustments amid evolving market conditions.

Singapore Airlines reported a 16.5% year-on-year decline in passenger traffic for January 2026, with total revenue passenger kilometers (RPK) falling to 3.2 million. Capacity, measured in available seat kilometers (ASK), decreased 12.8% to 3.8 million. Load factor slipped 5.2 percentage points to 84.2%. The carrier attributed the drop to reduced demand on long-haul routes and capacity adjustments amid evolving market conditions.

ET 00:46

Top Financial News at 12:28 a.m. EST

Global markets are mixed as investors digest Federal Reserve minutes and corporate earnings reports. The Dow Jones Industrial Average closed up 0.3% at 35,400, while the S&P 500 gained 0.4% to 4,650. The Nasdaq Composite slipped 0.2% to 14,200. Oil prices rose 1.5% to $82 per barrel amid concerns over OPEC+ supply cuts. Gold futures fell 0.8% to $1,900 as Treasury yields climbed. The U.S. dollar index edged higher, gaining 0.3% against a basket of major currencies.

Global markets are mixed as investors digest Federal Reserve minutes and corporate earnings reports. The Dow Jones Industrial Average closed up 0.3% at 35,400, while the S&P 500 gained 0.4% to 4,650. The Nasdaq Composite slipped 0.2% to 14,200. Oil prices rose 1.5% to $82 per barrel amid concerns over OPEC+ supply cuts. Gold futures fell 0.8% to $1,900 as Treasury yields climbed. The U.S. dollar index edged higher, gaining 0.3% against a basket of major currencies.

ET 00:46

Global Markets Update: Key Indices, Oil Prices, and Central Bank Actions

Global financial markets experienced mixed performance as central bank policies and geopolitical tensions influenced investor sentiment. The S&P 500 rose 0.4% to 4,320, while the Dow Jones Industrial Average gained 85 points to 34,250. The Nasdaq Composite slipped 0.2% to 13,850. European markets were flat, with the Stoxx 600 closing at 445. Asian indices showed resilience, with Japan's Nikkei 225 up 1.2% to 32,500 and China's CSI 300 gaining 0.8% to 3,800.
Crude oil prices fluctuated amid supply concerns. Brent crude settled at $85 per barrel, down 0.5% from the previous close, while West Texas Intermediate (WTI) declined 0.7% to $80 per barrel. The U.S. dollar index strengthened to 103.5, reflecting expectations of further Federal Reserve rate hikes. Gold prices dipped to $1,850 per ounce as yields on U.S. Treasuries climbed.

Global financial markets experienced mixed performance as central bank policies and geopolitical tensions influenced investor sentiment. The S&P 500 rose 0.4% to 4,320, while the Dow Jones Industrial Average gained 85 points to 34,250. The Nasdaq Composite slipped 0.2% to 13,850. European markets were flat, with the Stoxx 600 closing at 445. Asian indices showed resilience, with Japan's Nikkei 225 up 1.2% to 32,500 and China's CSI 300 gaining 0.8% to 3,800.

Crude oil prices fluctuated amid supply concerns. Brent crude settled at $85 per barrel, down 0.5% from the previous close, while West Texas Intermediate (WTI) declined 0.7% to $80 per barrel. The U.S. dollar index strengthened to 103.5, reflecting expectations of further Federal Reserve rate hikes. Gold prices dipped to $1,850 per ounce as yields on U.S. Treasuries climbed.